Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

InfuSystem Holdings (INFU) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to 5.99%.

  • InfuSystem Holdings' EBITDA Margin rose 21700.0% to 5.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.78%, marking a year-over-year increase of 32600.0%. This contributed to the annual value of 1.76% for FY2024, which is 13900.0% up from last year.
  • According to the latest figures from Q3 2025, InfuSystem Holdings' EBITDA Margin is 5.99%, which was up 21700.0% from 6.79% recorded in Q2 2025.
  • InfuSystem Holdings' 5-year EBITDA Margin high stood at 6.79% for Q2 2025, and its period low was 2.83% during Q1 2024.
  • Moreover, its 5-year median value for EBITDA Margin was 2.12% (2024), whereas its average is 1.62%.
  • The largest annual percentage gain for InfuSystem Holdings' EBITDA Margin in the last 5 years was 52900bps (2021), contrasted with its biggest fall of -409700bps (2021).
  • Over the past 5 years, InfuSystem Holdings' EBITDA Margin (Quarter) stood at 2.2% in 2021, then tumbled by -100bps to 0.01% in 2022, then plummeted by -14237bps to 1.49% in 2023, then soared by 341bps to 3.59% in 2024, then skyrocketed by 67bps to 5.99% in 2025.
  • Its EBITDA Margin was 5.99% in Q3 2025, compared to 6.79% in Q2 2025 and 1.49% in Q1 2025.